PRADAXA (Rebel Distributors Corp)
Welcome to the PulseAid listing for the PRADAXA drug offered from Rebel Distributors Corp. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Rebel Distributors Corp |
NON-PROPRIETARY NAME: | dabigatran etexilate mesylate |
SUBSTANCE NAME: | DABIGATRAN ETEXILATE MESYLATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2010-10-26 |
END MARKETING DATE: | 0000-00-00 |
PRADAXA HUMAN PRESCRIPTION DRUG Details:
Item Description | PRADAXA from Rebel Distributors Corp |
LABELER NAME: | Rebel Distributors Corp |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 150(mg/1) |
START MARKETING DATE: | 2010-10-26 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 21695-899_5db7f199-8752-4d24-85f7-e34ca8f4d02e |
PRODUCT NDC: | 21695-899 |
APPLICATION NUMBER: | NDA022512 |
Other DABIGATRAN ETEXILATE MESYLATE Pharmaceutical Manufacturers / Labelers: